Duplex, triplex and quadruplex PCR for the preimplantation genetic diagnosis (PGD) of cystic fibrosis (CF), an exhaustive approach

Most of cystic fibrosis (CF) pre‐implantation genetic diagnosis (PGD) cases described to date are limited to the detection of ΔF508. Beside this predominant mutation, over 1000 mutations have been identified, rendering the development of a mutation‐based PGD protocol impracticable. This is the reason why we, as well as the others, have developed PGD strategies on the basis of the identification of the pathogenic haplotype instead of the mutation(s). In a previous article, we reported the conditions for the co‐amplification of two intragenic polymorphic markers and the F508 locus. Here we describe an improved protocol allowing the additional amplification of two new intragenic markers, intron 1 CA repeat (I1CA) and IVS17bTA. This new protocol should, theoretically, allow us to provide a diagnosis to all couples requiring PGD for CF. Using single lymphoblasts, we have tested four different PCR configurations, including one duplex, two triplexes and one quadruplex PCR. All of them gave results compatible with a clinical application. The number of single lymphoblasts tested in each series varied from 89 to 155. PCR efficiency ranged from 95.4 to 100%. A complete haplotype was achieved for 83.2 to 90.7% of the tested cells, with an allele drop out (ADO) rate comprised between 6.0 and 11.6%. We present here three cases that we performed either with the former test (one case using the triplex PCR combining F508, IVS8CA and IVS17bCA) or with the new one (one case using the triplex combining F508, I1CA and IVS17bTA and one case using a quadruplex test). We obtained two single pregnancies. Copyright © 2004 John Wiley & Sons, Ltd.

[1]  P. Devroey,et al.  Improving clinical preimplantation genetic diagnosis for cystic fibrosis by duplex PCR using two polymorphic markers or one polymorphic marker in combination with the detection of the DeltaF508 mutation. , 2003, Molecular human reproduction.

[2]  C. Moutou,et al.  Multiplex PCR combining deltaF508 mutation and intragenic microsatellites of the CFTR gene for pre-implantation genetic diagnosis (PGD) of cystic fibrosis , 2002, European Journal of Human Genetics.

[3]  I. Durieu,et al.  Cystic fibrosis phenotype evaluation and paternity outcome in 50 males with congenital bilateral absence of vas deferens. , 2001, Human reproduction.

[4]  C. Moutou,et al.  Allele‐specific amplification for preimplantation genetic diagnosis (PGD) of spinal muscular atrophy , 2001, Prenatal diagnosis.

[5]  M. Schwartz,et al.  Single intragenic microsatellite preimplantation genetic diagnosis for cystic fibrosis provides positive allele identification of all CFTR genotypes for informative couples. , 2001, Molecular human reproduction.

[6]  S. Viville,et al.  ESHRE preimplantation genetic diagnosis (PGD) consortium: data collection II (May 2000). , 2000, Human reproduction.

[7]  C. Clavel,et al.  Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France , 2000, Human mutation.

[8]  M. Loriot,et al.  Histological and genetic analysis and risk assessment for chromosomal aberration after ICSI for patients presenting with CBAVD. , 2000, Human reproduction.

[9]  J. Dreesen,et al.  Multiplex PCR of polymorphic markers flanking the CFTR gene; a general approach for preimplantation genetic diagnosis of cystic fibrosis. , 2000, Molecular human reproduction.

[10]  K. Kidd,et al.  Allele Frequencies in a Worldwide Survey of a CA Repeat in the First Intron of the CFTR Gene , 1999, Human Heredity.

[11]  W. Lissens,et al.  The genetics of male infertility in relation to cystic fibrosis. , 1997, Bailliere's clinical obstetrics and gynaecology.

[12]  Arie,et al.  Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. , 1995, The New England journal of medicine.

[13]  X. Estivill,et al.  Multiplex PCR amplification of three microsatellites within the CFTR gene. , 1992, Genomics.

[14]  J. Mandel,et al.  On some technical aspects of direct DNA diagnosis of the fragile X syndrome. , 1992, American journal of medical genetics.

[15]  A. Handyside,et al.  Biopsy of cleavage stage human embryos and diagnosis of single gene defects by DNA amplification. , 1992, Archives of pathology & laboratory medicine.

[16]  L. Tsui,et al.  A cluster of highly polymorphic dinucleotide repeats in intron 17b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. , 1991, American journal of human genetics.

[17]  X. Estivill,et al.  Dinucleotide (CA/GT) repeat polymorphism in intron 17B of the cystic fibrosis transmembrane conductance regulator (CFTR) gene , 2004, Human Genetics.

[18]  S. Viville,et al.  ESHRE preimplantation genetic diagnosis consortium: Data collection III (May 2001) , 2002 .

[19]  Eshre Pgd.  ESHRE Preimplantation Genetic Diagnosis Consortium: data collection III (May 2001). , 2002, Human reproduction.

[20]  C. Lewis,et al.  Controlling misdiagnosis errors in preimplantation genetic diagnosis: a comprehensive model encompassing extrinsic and intrinsic sources of error. , 2001, Human reproduction.

[21]  I. Durieu,et al.  Cystic fibrosis phenotype evaluation and paternity outcome in 50 males with congenital bilateral absence of vas deferens , 2001 .

[22]  Eshre Pgd.  ESHRE Preimplantation Genetic Diagnosis ( PGD ) Consortium : data collection II ( May 2000 ) ESHRE PGD Consortium Steering Committee , 2000 .

[23]  A. Harris,et al.  A CA repeat in the first intron of the CFTR gene. , 1997, Human Heredity.